{"id":"W2768023721","doi":"10.1016/j.jval.2017.09.009","title":"Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":124,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Canada","funders":"","keywords":"Tolerability; Clinical trial; Food and drug administration; Drug development; Medicine; Terminology; Adverse effect; Common Terminology Criteria for Adverse Events; Alternative medicine; Patient-reported outcome; Regulatory science; Drug; Medical physics; Pharmacology; Internal medicine; Pathology; Nursing; Quality of life (healthcare)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1437051,0.001440677,0.001353393,0.001738825,0.0006586823,0.005545345,0.002132282,0.005693241,0.002570176],"category_scores_gemma":[0.1097053,0.0006638197,0.002559909,0.001499136,0.001634485,0.004134275,0.001910456,0.01122812,0.0005502042],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005042971,"about_ca_system_score_gemma":0.0143575,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006997067,"about_ca_topic_score_gemma":0.01085031,"domain_scores_codex":[0.9785824,0.01369959,0.001825693,0.000893796,0.004341712,0.0006568784],"domain_scores_gemma":[0.8016983,0.1378545,0.007810348,0.004149457,0.04457759,0.003909772],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002784,0.00109824,0.005656123,0.002022982,0.0007926244,0.000221696,0.0009984454,0.002141534,0.001840637,0.01362233,0.1901035,0.7787179],"study_design_scores_gemma":[0.002775738,0.005374611,0.03328659,0.03259569,0.003383896,0.0005350865,0.002467991,0.01167574,0.01485598,0.06452031,0.8279388,0.0005896931],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.01720046,0.1802819,0.03023024,0.7470279,0.007798003,0.00142283,0.002424623,0.0001568735,0.01345707],"genre_scores_gemma":[0.2434387,0.314943,0.1791569,0.220345,0.02415747,0.00344233,0.002865599,0.0002141054,0.01143697],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.8562949,"threshold_uncertainty_score":0.7599943,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6308552548625395,"score_gpt":0.5046292452090074,"score_spread":0.126226009653532,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}